fda stopping compounded tirzepatide Weight Loss Program | GLP-1 Treatment FDA confirms tirzepatide shortage is

The 30-year-old Queens resident started gaining weight during the COVID pandemic as her lifestyle became more sedentary

She felt trapped in a cycle, too nauseous to eat, but the nausea worsened when she didnt eat

In the 12 mg group, a substantial proportion of participants achieved weight loss of 15% or more, and many exceeded 20% thresholds considered clinically meaningful in obesity medicine

Weve found that some patients respond better to one medication over the other, which is why we carefully evaluate each persons needs before recommending either option

Are semaglutide, liraglutide, tirzepatide or other GLP-1 agonists really the miracle weight-loss drugs